-
Loading metrics
Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions
- Alastair J. King,
- Marc R. Arnone,
- Maureen R. Bleam,
- Katherine G. Moss,
- Jingsong Yang,
- Kelly E. Fedorowicz,
- Kimberly N. Smitheman,
- Joseph A. Erhardt,
- Angela Hughes-Earle,
- Laurie S. Kane-Carson
![PLOS](/resource/img/logo-plos.png)
x
- Published: July 3, 2013
- https://doi.org/10.1371/journal.pone.0067583